15 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

SafeSharp Transseptal Needle (CLICK071, CLICK171, CLICK098, CLICK198)

FDA 510(k)
FDA Class 2 ·Cardiovascular

Mui Scientific

FDA UDI
H & A Mui Enterprises Inc·10678467507850·24-Channel Customized Single-Use Anorectal Cath...

MCARE PF POWDER FREE LATEX EXAMINATION HIGH RISK GLOVES

FDA 510(k)
FDA Class 1 ·General Hospital

SPLIT SEPTUM INJECTION SITES

FDA 510(k)
FDA Class 2 ·General Hospital

ALINITY C CALCIUM2

FDA Adverse Event
Malfunction ·ABBOTT IRELAND DIAGNOSTICS DIVISION·Product code CJY·March 5, 2026

PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP

FDA Adverse Event
Malfunction ·MEDTRONIC PUERTO RICO OPERATIONS CO.·Product code OYC·November 10, 2014

DEEP BRAIN STIMULATION LEAD

FDA Adverse Event
Malfunction ·MPROC, VILLALBA·Product code MHY·August 17, 2011

6600

FDA Adverse Event
Malfunction ·GE OEC MEDICAL SYSTEMS (SLC)·Product code JAA·July 18, 2013

LIBERTY CYCLER SET, SINGLE CONN./EXT. DL

FDA Adverse Event
Malfunction ·REYNOSE MANUFACTURING·Product code FKX·August 19, 2011

BELLATEK HYBRID BAR 4 IMPLANTS

FDA Adverse Event
Malfunction ·BIOMET 3I·Product code NHA·December 26, 2024

BELLATEK HYBRID BAR 4 IMPLANTS

FDA Adverse Event
Malfunction ·BIOMET 3I·Product code NHA·January 6, 2025

BELLATEK¿ HYBRID BAR 5 IMPLANTS

FDA Adverse Event
Malfunction ·BIOMET 3I·Product code NHA·February 18, 2025

BELLATEK HYBRID BAR 5 IMPLANTS

FDA Adverse Event
Malfunction ·BIOMET 3I·Product code NHA·March 18, 2025

BELLATEK HYBRID BAR 4 IMPLANTS

FDA Adverse Event
Malfunction ·BIOMET 3I·Product code NHA·January 6, 2025

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014